There was also a significantly increased hazard for patients with a canonical KRAS variation: patients whose tumor carried a canonical KRAS variation had increased likelihood of death compared with those without KRAS variation (HR, 1.45; 95% CI, 1.16-1.82) (eTable 4, eFigure 4 in the Supplement). Here, KRAS is linked to neoplasm.